Word

FISCLOZA

Status

Registered

Status Code

700

Status Date

Tuesday, April 11, 2023

Serial Number

97155054

Registration Number

7022285

Registration Date

Tuesday, April 11, 2023

Mark Type

4000

Filing Date

Friday, December 3, 2021

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

TiGenix, S.A.U. - Original Registrant

Classifications

5 Pharmaceutical preparations for use in gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's diseases patients; cellular functioning activating agents, biological or bacteriological preparations for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants in the nature of implants comprising living tissue or engineered live cellular tissue in the nature of implants comprising living tissue for medical purposes for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients

Trademark Events

Apr 11, 2023

Notice Of Registration Confirmation Emailed

Apr 11, 2023

Registered-Principal Register

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 17, 2022

Approved For Pub - Principal Register

Nov 23, 2022

Teas/Email Correspondence Entered

Nov 23, 2022

Correspondence Received In Law Office

Nov 23, 2022

Assigned To Lie

Oct 5, 2022

Teas Response To Office Action Received

Sep 20, 2022

Notification Of Non-Final Action E-Mailed

Sep 20, 2022

Non-Final Action E-Mailed

Sep 20, 2022

Non-Final Action Written

Sep 13, 2022

Assigned To Examiner

Dec 7, 2021

New Application Office Supplied Data Entered

Dec 7, 2021

New Application Entered